A phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.
B. Halmos
Research Funding - Sanofi
J. A. Bokar
No relevant relationships to disclose
P. Fu
No relevant relationships to disclose
D. J. Adelstein
Research Funding - AstraZeneca; Sanofi
R. A. Juergens
No relevant relationships to disclose
M. B. Rodal
No relevant relationships to disclose
A. Dowlati
No relevant relationships to disclose